Stocks and Investing Stocks and Investing
Wed, September 18, 2024
Tue, September 17, 2024

Akash Tewari Upgraded (BNTX) to Strong Buy and Increased Target to $150 on, Sep 17th, 2024


Published on 2024-10-28 14:19:14 - WOPRAI, Akash Tewari
  Print publication without navigation


Akash Tewari of Jefferies, Upgraded "BioNTech SE" (BNTX) to Strong Buy and Increased Target from $96 to $150 on, Sep 17th, 2024.

Akash has made no other calls on BNTX in the last 4 months.



There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 2 agree with Akash's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jessica Fye of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $125 on, Monday, September 16th, 2024
  • Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $85 on, Tuesday, August 6th, 2024


These are the ratings of the 3 analyists that currently disagree with Akash


  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $113 on, Monday, September 16th, 2024
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $150 on, Monday, September 16th, 2024
  • Emmanuel Papadakis of "Deutsche Bank" Upgraded from Hold to Strong Buy and Held Target at $95 on, Wednesday, August 7th, 2024
Contributing Sources